Neurostimulation Devices Market Size, Share, Growth, Report, Forecast, Analysis, Segmentation, Outlook, Overview, Statistics | Valuates Reports

Neurostimulation Devices Market

The global Neurostimulation Devices market size is estimated to be worth US$ 7454.1 million in 2022 and is forecast to a readjusted size of US$ 14170 million by 2028 with a CAGR of 11.3% during the review period. Key drivers of the neurostimulation devices market include the growing number of neurological disorders such as Parkinson's disease, Epilepsy, depression, chronic pain, etc. The rise in the geriatric population is also contributing to the market expansion. The increasing R&D initiatives for developing technologically advanced devices and increasing trends for minimally invasive surgeries, drug-free treatment, and therapeutic potential are expected to propel the neurostimulation devices market in the coming years.

Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15158/Global_Neurostimulation_Devices_Market_Insights_and_Forecast_to_2027

Neurostimulation Devices Market Trends

Increasing geriatric population and the growing number of neurological disorders

The geriatric population is growing due to the rapid extension of life expectancy around the world. Prolonged aging has increased the occurrence of several non-communicable, chronic, and progressive diseases. Neurological disorders such as Dementia, Epilepsy, Stroke, Parkinson's disease, Depression, etc are becoming common across the entire globe. The frequency and severity of these diseases have also risen leading to a reduction in the quality of life of the patients. Thus growing nerve disorders is augmenting the need for neurostimulation methods thereby accelerating the neurostimulation devices market during the review period.

R&D initiatives for new developments and the growing popularity of minimally invasive surgery

The growing research and development initiatives for advanced neurostimulation technology devices along with a better understanding of neurocircuitry, neuroimaging has increased the use of these devices for providing therapeutic relief to patients suffering from a wide range of mental health diseases. Further, the growing preference for minimally invasive surgeries and drug-free treatments has also contributed to the growth. Thus the above-mentioned factors are expected to surge the neurostimulation devices market expansion in the coming years.

Neurostimulation Devices Market Share Analysis

Based on region, North America is expected to dominate the neurostimulation devices market share with 40% followed by China, Europe with a total share of 40%. North America will grow due to quick approvals and the development of innovative technologies.

Based on type, Spinal Cord Stimulation is expected to provide lucrative opportunities for growth in the Neurostimulation Devices market share with 55% due to large scale product application and increasing market penetration.

Based on application, the pain management segment is expected to provide ample opportunities for growth in the neurostimulation devices market share due to rising chronic pain diseases and extensive use of these devices for pain management.

Market By Type
• Spinal Cord Stimulation (SCS)
• Gastric Electric Stimulation (GES)
• Deep Brain Stimulation (DBS)
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation (VNS)
• Other

Market By Application
• Pain Management
• Parkinson's Disease
• Urinary and Fecal Incontinence
• Epilepsy
• Gastroparesis
• Other

Market By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• China Taiwan
• Indonesia
• Thailand
• Malaysia
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE

Market By Company
• Medtronic
• Boston Scientific
• Abbott
• LivaNova
• Nevro
• NeuroPace
• Beijing Pins
• Synapse Biomedical

View Full Report: https://reports.valuates.com/reports/QYRE-Auto-15158/global-neurostimulation-devices

Similar Reports:

1. https://reports.valuates.com/market-reports/QYRE-Auto-23S451/global-implantable-neurostimulation-devices

2. https://reports.valuates.com/market-reports/QYRE-Auto-13H8123/global-internal-neurostimulation-devices

3. https://reports.valuates.com/market-reports/QYRE-Auto-21I9913/global-external-neurostimulation-device

https://reports.valuates.com/sitemap/html/reports/569
https://reports.valuates.com/sitemap/html/reports/570
https://reports.valuates.com/sitemap/html/reports/571

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.